UFP Technologies, Inc. is an American multinational developer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products. UFP Technologies manufactures a wide range of single-use medical devices, components, and packaging for minimally invasive surgery, infection prevention, wound care, wearables, orthopedic soft goods, and orthopedic implants.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| UFPT | UFP TECHNOLOGIES INC | 2026-03-03 13:32:18 | 200.03 | -4.27 | -2.07 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| UFPT | 0000914156 | UFP TECHNOLOGIES INC | US9026731029 | 549300RJ8LY41HS70C91 | 042314970 | Nasdaq | 3841 | Surgical & Medical Instruments & Apparatus | 1231 | DE | 100 HALE STREET | NEWBURYPORT | MA | 01950 | UNITED STATES | US | 978-352-2200 | 100 HALE STREET, NEWBURYPORT, MA, 01950 | 100 HALE STREET, NEWBURYPORT, MA, 01950 | — | — | 1963 | R. Jeffrey Bailly | 3,293 | — | 1,915,822,594 | 7,742,003 | 7,712,444 | UFP Technologies, Inc. is an American multinational developer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products. UFP Technologies manufactures a wide range of single-use medical devices, components, and packaging for minimally invasive surgery, infection prevention, wound care, wearables, orthopedic soft goods, and orthopedic implants. | 2026-02-26 17:29:54 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2024 | 1,915,822,594 | 531,929,770 | 38.4372 | 7,680,305 | 38,422 | 0.5028 |
| 2023 | 1,383,892,824 | 830,967,498 | 150.2857 | 7,641,883 | 31,832 | 0.4183 |
| 2022 | 552,925,326 | 158,751,151 | 40.2744 | 7,610,051 | 48,556 | 0.6421 |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Christopher P. Litterio | Secretary, Senior Vice President, General Counsel | 2024 | 370,000 | 0 | 303,892 | 233,276 | 32,250 | 939,418 |
| Jason Holt | Chief Commercial Officer, Vice President | 2024 | 338,000 | 0 | 197,975 | 178,518 | 29,391 | 743,884 |
| Ronald J. Lataille | Chief Financial Officer, Treasurer, Senior Vice President | 2024 | 460,000 | 0 | 741,416 | 354,094 | 36,786 | 1,592,296 |
| Mitchell C. Rock | President | 2024 | 500,000 | 0 | 871,090 | 386,794 | 36,411 | 1,794,295 |
| Christopher P. Litterio | Secretary, Senior Vice President, General Counsel | 2023 | 355,000 | 0 | 273,000 | 253,000 | 31,517 | 912,517 |
| Fiscal Year | Employee Count |
|---|---|
| 2025 | 4,846 |
| 2024 | 4,146 |
| 2023 | 3,093 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | 602,797,000 | 504,421,000 | 400,072,000 |
| Cost Of Revenue | 432,387,000 | 357,728,000 | 287,847,000 |
| Gross Profit | 170,410,000 | 146,693,000 | 112,225,000 |
| Research And Development Expenses | 8,600,000 | 10,400,000 | 7,200,000 |
| General And Administrative Expenses | 77,439,000 | 62,218,000 | 50,889,000 |
| Operating Expenses | — | — | — |
| Operating Income | 92,338,000 | 80,897,000 | 57,664,000 |
| Net Income | 68,313,000 | 58,981,000 | 44,924,000 |
| Earnings Per Share Basic | 8.87 | 7.69 | 5.89 |
| Earnings Per Share Diluted | 8.75 | 7.58 | 5.83 |
| Weighted Average Shares Outstanding Basic | 7,705,000 | 7,668,000 | 7,624,000 |
| Weighted Average Shares Outstanding Diluted | 7,804,000 | 7,785,000 | 7,701,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Cash And Cash Equivalents | 20,301,000 | 13,450,000 | 5,263,000 |
| Marketable Securities Current | — | — | — |
| Accounts Receivable | 82,914,000 | 84,677,000 | 64,449,000 |
| Inventories | 86,856,000 | 87,536,000 | 70,191,000 |
| Non Trade Receivables | 5,310,000 | 4,979,000 | 1,297,000 |
| Other Assets Current | 5,620,000 | 4,303,000 | 3,433,000 |
| Total Assets Current | 201,001,000 | 194,945,000 | 144,633,000 |
| Marketable Securities Non Current | — | — | — |
| Property Plant And Equipment | 79,109,000 | 70,564,000 | 62,137,000 |
| Other Assets Non Current | 3,444,000 | 447,000 | 469,000 |
| Total Assets Non Current | 454,076,000 | 434,050,000 | 259,503,000 |
| Total Assets | 655,077,000 | 628,995,000 | 404,136,000 |
| Accounts Payable | 24,289,000 | 24,269,000 | 22,286,000 |
| Deferred Revenue | 4,240,000 | 4,667,000 | 6,616,000 |
| Short Term Debt | 12,500,000 | 12,500,000 | 4,000,000 |
| Other Liabilities Current | 28,796,000 | 30,410,000 | 22,085,000 |
| Total Liabilities Current | 74,862,000 | 76,295,000 | 58,209,000 |
| Long Term Debt | 135,455,000 | 189,375,000 | 32,000,000 |
| Other Liabilities Non Current | 3,525,000 | 11,144,000 | 15,181,000 |
| Total Liabilities Non Current | 156,338,000 | 209,940,000 | 59,836,000 |
| Total Liabilities | 231,200,000 | 286,235,000 | 118,045,000 |
| Common Stock | 77,000 | 77,000 | 76,000 |
| Retained Earnings | 374,814,000 | 306,501,000 | 247,520,000 |
| Accumulated Other Comprehensive Income | 3,708,000 | -4,165,000 | 268,000 |
| Total Shareholders Equity | 423,877,000 | 342,760,000 | 286,091,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Depreciation And Amortization | 9,400,000 | 8,000,000 | 7,000,000 |
| Share Based Compensation Expense | 8,854,000 | 6,842,000 | 4,641,000 |
| Other Non Cash Income Expense | -38,000 | -106,000 | -145,000 |
| Change In Accounts Receivable | -5,337,000 | -1,217,000 | 9,124,000 |
| Change In Inventories | -3,901,000 | 4,686,000 | 16,565,000 |
| Change In Non Trade Receivables | 548,000 | 3,404,000 | 2,982,000 |
| Change In Other Assets | 5,996,000 | -629,000 | -1,557,000 |
| Change In Accounts Payable | -1,090,000 | -1,142,000 | 1,553,000 |
| Change In Other Liabilities | -5,741,000 | -6,541,000 | 408,000 |
| Cash From Operating Activities | 91,905,000 | 66,593,000 | 41,334,000 |
| Purchases Of Marketable Securities | — | — | — |
| Sales Of Marketable Securities | — | — | — |
| Acquisition Of Property Plant And Equipment | — | 9,656,000 | 10,490,000 |
| Acquisition Of Business | 14,722,000 | 197,477,000 | 0 |
| Other Investing Activities | — | — | — |
| Cash From Investing Activities | -27,597,000 | -210,164,000 | -10,488,000 |
| Tax Withholding For Share Based Compensation | 4,117,000 | 4,954,000 | 2,641,000 |
| Payments Of Dividends | — | — | — |
| Issuance Of Common Stock | — | — | — |
| Repurchase Of Common Stock | — | — | — |
| Issuance Of Long Term Debt | 0 | 125,000,000 | 0 |
| Repayment Of Long Term Debt | 12,500,000 | 35,125,000 | 4,000,000 |
| Other Financing Activities | — | — | — |
| Cash From Financing Activities | -58,156,000 | 152,393,000 | -30,024,000 |
| Change In Cash | 6,851,000 | 8,187,000 | 812,000 |
| Cash At End Of Period | 20,301,000 | 13,450,000 | 5,263,000 |
| Income Taxes Paid | 3,558,000 | 12,829,000 | 10,568,000 |
| Interest Paid | 9,855,000 | 7,893,000 | 3,537,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Earnings Per Share | 8.87 | 7.69 | 5.89 |
| Price To Earnings Ratio | 25.0316 | 31.7958 | 29.2088 |
| Earnings Growth Rate | 15.3446 | 30.5603 | 6.7029 |
| Price Earnings To Growth Ratio | 1.6313 | 1.0404 | 4.3576 |
| Book Value Per Share | 55.0132 | 44.7001 | 37.5251 |
| Price To Book Ratio | 4.0359 | 5.47 | 4.5847 |
| Ebitda | 91,075,000 | 87,871,000 | 66,137,000 |
| Enterprise Value | 1,838,395,150 | 2,063,327,680 | 1,342,369,960 |
| Dividend Yield | — | — | — |
| Dividend Payout Ratio | — | — | — |
| Debt To Equity Ratio | 0.3491 | 0.589 | 0.1258 |
| Capital Expenditures | 17,945,000 | 16,427,000 | 11,065,000 |
| Free Cash Flow | 73,960,000 | 50,166,000 | 30,269,000 |
| Return On Equity | 0.1612 | 0.1721 | 0.157 |
| One Year Beta | 0.8434 | 1.7315 | 0.9252 |
| Three Year Beta | 1.0623 | 0.9008 | 0.7718 |
| Five Year Beta | 0.8923 | 0.8569 | 0.7805 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| BAILLY R JEFFREY | Director, CEO | 2026-02-10 | 7,428 | A | 160,524 |
| BAILLY R JEFFREY | Director, CEO | 2026-02-10 | 19,061 | A | 179,585 |
| LATAILLE RONALD J | Chief Financial Officer | 2026-02-10 | 2,463 | A | 15,460 |
| LATAILLE RONALD J | Chief Financial Officer | 2026-02-10 | 3,115 | A | 18,575 |
| ROCK MITCHELL | President | 2026-02-10 | 2,463 | A | 35,463 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| Pacer Advisors, Inc. | 2025-12-31 | 112,569 | 507 | 222.0296 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2025-12-31 | 40,296,000 | 181,483 | 222.0373 |
| OSAIC HOLDINGS, INC. | 2025-12-31 | 10,420,310 | 46,932 | 222.03 |
| Tower Research Capital LLC (TRC) | 2025-12-31 | 46,626 | 210 | 222.0286 |
| JANUS HENDERSON GROUP PLC | 2025-12-31 | 17,616,279 | 79,391 | 221.8926 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| JAMES ADVANTAGE FUNDS | 2025-12-31 | JAMES MICRO CAP FUND | JMCRX | 1,193 | 264,881.79 | 0.9809 |
| RYDEX SERIES FUNDS | 2025-12-31 | Class C | RYCMX | 10 | 2,220.3 | 0.0263 |
| RYDEX SERIES FUNDS | 2025-12-31 | Class A | RYAKX | 10 | 2,220.3 | 0.0263 |
| RYDEX SERIES FUNDS | 2025-12-31 | Class H | RYMKX | 10 | 2,220.3 | 0.0263 |
| RYDEX DYNAMIC FUNDS | 2025-12-31 | H-Class Shares | RYRSX | 38 | 8,437.14 | 0.0155 |